Which account would you like to be logged in as?

Forgot Password?

Sign Up!

Visa/MasterCard and Discover Users
Flip your credit card over and look at the signature box. You should see either the entire 16-digit credit card number or just the last four digits followed by a special 3-digit code. The 3-digit code is your Card Security Code.

American Express Credit Card Users
Look for the 4-digit code printed on the front of your card just above and to the right of your main credit card number. The 4-digit code is your card Identification Number (CID).

What is a discount code?
Generic discount code text needs to go here

View All Live Meetings
Chronic Myelogenous Leukemia

Chronic Myeloid Leukemia: Evaluating the Evolving Therapeutic Landscape To Improve Outcomes

dec
7

Atlanta, GA
12:30 PM - 4:30 PM

Register Now

Location

Georgia World Congress Center
Georgia Ballroom 1
285 Andrew Young International Boulevard
Atlanta, GA 30313

Please click here for a Google Map to meeting location

Chair


Neil P. Shah, MD, PhD

Associate Professor in Residence
Edward S. Ageno Distinguished Professor in Hematology/Oncology
Leader, Hematopoietic Malignancies Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California


Faculty


Jorge Cortes, MD

D. B. Lane Cancer Research
Distinguished Professor for Leukemia Research
Deputy Chairman, Section Chief of AML & CML
Department of Leukemia
The University of Texas
MD Anderson Cancer Center
Houston, Texas


Michael J. Mauro, MD

Leader, Myeloproliferative Disorders Program
Memorial Sloan-Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, New York


Jerald P. Radich, MD

Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Professor of Medicine
University of Washington School of Medicine
Seattle, Washington


Neil P. Shah, MD, PhD

Associate Professor in Residence
Edward S. Ageno Distinguished Professor in Hematology/Oncology
Leader, Hematopoietic Malignancies Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California


Paul J. Shami, MD

Professor of Medicine
Division of Hematology and Hematologic Malignancies
University of Utah
Huntsman Cancer Institute
Salt Lake City, Utah


David S. Snyder, MD

Associate Chair, Hematology & Hematopoietic Cell Transplantation
Professor of Hematology/HCT
Member, Hematologic Malignancies Program
City of Hope
Duarte, California


Educational Objectives

At the conclusion of this activity, participants should be able to:

  • Implement evidence-based therapeutic strategies in the frontline and second-line treatment of patients with chronic phase chronic myeloid leukemia (CML-CP)
  • Consider known toxicity profiles of tyrosine kinase inhibitor (TKI) therapy to individualize the selection of these agents for initial and subsequent management
  • Review the use of hematologic, cytogenetic, and molecular responses to monitor patients with CML-CP receiving TKI therapy, and analyze strategies for overcoming resistance to TKIs
  • Evaluate how BCR-ABL mutations may influence the selection of TKIs for the treatment of CML-CP
  • Assess the role of allogeneic hematopoietic stem cell transplantation in patients with CML-CP
  • Recall the ongoing clinical trials evaluating innovative investigational approaches for CML to aid appropriate patients for study participation

Agenda



Description

 

TARGET AUDIENCE
The intended audience for this program is medical oncologists, hematologists, hematologist-oncologists, hematopathologists, oncology specialty pharmacists, and nurses.

PHYSICIAN CONTINUING EDUCATION
ACCREDITATION STATEMENT

Educational Concepts Group, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
Educational Concepts Group, LLC designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACIST CONTINUING EDUCATION
ACPE Logo Educational Concepts Group, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Educational Concepts Group, LLC designates this continuing education activity for 3.5 contact hours (0.35 CEUs) (UAN 0199-0000-12-032-L01-P).

Type of activity: Application-based

CME/CE CREDIT
There are no fees for participating and receiving CME/CE credits for this activity. Participants who complete an activity evaluation form and return it to Educational Concepts Group, LLC may view and print their credit letter or statement of credit via the website, www.educationalconcepts.net, 6 weeks after the activity.

FACULTY DISCLOSURE STATEMENT
All faculty participating in continuing education activities sponsored by ECG are expected to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations/materials.

REGISTRATION DETAILS
Registration before Sunday, December 02, 2012 is requested. You will receive confirmation of your registration by e-mail or fax. On-site registration is limited to space availability.

REGISTRATION FEE: NONE

QUESTIONS?
Please contact Nicole Neely at Educational Concepts Group, LLC
Phone: 1.866.938.2052 | E-mail: nneely@educationalconcepts.net | Fax: 404.994.2779

AMERICANS WITH DISABILITIES ACT (ADA)
ECG staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Nicole Neely prior to the live event at 1.866.938.2052.

This activity is sponsored by Educational Concepts Group, LLC.

This activity is supported by an educational grant from the following: This activity is supported by an educational grant from the following: Bristol-Myers Squibb/Otsuka America Pharmaceutical, Inc.